Related Experiment Video
Updated: Sep 20, 2026

08:07
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
Published on: April 7, 2023
In vitro effects of bipathic treatment with antibodies in ultralow doses during long-term post-tetanic potentiation
O I Epstein1, N A Beregovoi, T M Pankova
1Materia Medica Holding Research-and-Production Company, Moscow.
Bulletin of Experimental Biology and Medicine
|September 2, 2003
Abstract:
We studied the effects of individual or combination treatment with monoclonal antibodies 5F5-B6 in ultralow doses specifically marking mossy fibers in rat hippocampus and antibodies to S100 protein during long-term post-tetanic potentiation in hippocampal slices. The possible mechanisms of changes produced by therapeutic administration of antibodies in ultralow doses were revealed.

